Fox Chase Cancer Center: Avapritinib Provided Greater Benefit Than Other Tyrosine Kinase Inhibitors for Mutated Gastrointestinal Stromal Tumors

Press/Media

PeriodMay 18 2021

Media coverage

1

Media coverage

  • TitleFox Chase Cancer Center: Avapritinib Provided Greater Benefit Than Other Tyrosine Kinase Inhibitors for Mutated Gastrointestinal Stromal Tumors
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date05/18/21
    PersonsMargaret von Mehren
View all 1
View less